Eiger BioPharmaceuticals, Inc.
EIGR
|
NASDAQ
|
0 Obserwujący
Company Quality
Profitability Score
17/100
Solvency Score
5/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Branża
Dr. David Apelian M.B.A., M.D., Ph.D.
Prezes
56
Pracownicy
Palo Alto
Siedziba główna
US
Kraj
Key Metrics TTM
Valuation
Market cap.
$2.6MEnterprise Value
$18MPrice to Earnings
-0.03Price to Sales
0.16Price to Book
-0.18Price to Cash Flow
-0.03Profitability
Return on Assets
-193.07%Return on Equity
-367.00%Return on Invested Capital
-268.43%Gross Margin
99.85%Operating Margin
-455.12%Net Margin
-475.26%Liquidity
Quick Ratio
0.68Current Ratio
0.71Cash Ratio
0.48Inventory Turnover
0.02Asset Turnover
0.41Total Liabilities
$53MSolvency
Debt to Assets
1.06Debt to Equity
N/AInterest Coverage
-13.13Equity Ratio
-0.37Long-term Debt to Cap.
0.00Altman Z-Score
-24.48Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.